Enhancing the utility of deer mice as an infectious disease model
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 1R24AI186970-01A1
Grant search
Key facts
Disease
N/A
Start & end year
20252030Known Financial Commitments (USD)
$466,725Funder
National Institutes of Health (NIH)Principal Investigator
Ioulia ChatzistamouResearch Location
United States of AmericaLead Research Institution
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIAResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Not applicable
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Abstract Deer mice (genus Peromyscus) are the most abundant mammals in North America. In biomedical research, their most prominent use is in the field of infectious diseases, because they are the natural reservoir of infectious agents such as Borrelia burgdorferi which causes Lyme disease, for Hantaviruses, Sin Nombre Virus, and SARS-CoV-2 that caused the COVID-19 pandemic. The University of South Carolina operates, for more than 40 years, the Peromyscus Genetic Stock Center (PGSC) that is charged with the mission of maintaining different stocks of Peromyscus, supplying them to outside investigators and exploiting deer mouse- related research. The present proposal addresses 3 major unmet needs of the Peromyscus community of researchers that impede the use of deer mice as a model and are related to the poor breeding program that does not enable rapid availability if deer mice to users, the lack of Peromyscus-specific antibodies, and the lack of readily access to breeding records for pedigree analyses. Here, we request funds to enhance the utility of deer mice as a model of relevance to NIAID's interests by (1) strengthening the breeding capacities of the PGSC, (2) by developing specialized immunological reagents such as Peromyscus-specific antibodies, and (3) by curating our electronic databases and rendering them easily accessible to outside users. Plans for the project's sustainability have been developed, and it is anticipated that upon completion it will be supported fully by the income generated.